Navigation Links
Spherix Incorporated to Present at the Rodman & Renshaw 13th Annual Healthcare Conference
Date:9/6/2011

BETHESDA, Md., Sept. 6, 2011 /PRNewswire/ -- Spherix Incorporated (NASDAQ: SPEX) -- an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis, and providers of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies -- today announced that Dr. Claire Kruger, Chief Executive Officer, and Dr. Robert Lodder, President, will be presenting a corporate overview at the Rodman & Renshaw 13th Annual Healthcare Conference at 3:40 p.m. on September 12, 2011, in Metropolitan West of the Waldorf Astoria in New York.  The conference will be held from September 11-13, 2011.

A live audio and archived webcast of Spherix's presentation will be available through the Investor Relations section of the Company's website.

About Spherix

Spherix Incorporated was launched in 1967 as a scientific research company under the name Biospherics Research.  The Company now leverages its scientific and technical expertise and experience through its two subsidiaries -- Biospherics Incorporated and Spherix Consulting, Inc.  Biospherics is dedicated to developing and licensing/marketing proprietary therapeutic products for treatment of diabetes, metabolic syndrome and atherosclerosis.  Biospherics is actively seeking a pharmaceutical partner to continue the development of its Phase 3 compound for the treatment of diabetes, D-tagatose, while exploring new drugs and combinations for treatment of high triglycerides, a risk factor for atherosclerosis, myocardial infarction, and stroke.  Spherix's Consulting subsidiary provides scientific and strategic support for suppliers, manufacturers, distributors and retailers of conventional foods, biotechnology-derived foods, medical foods, infant formulas, food ingredients, dietary supplements, food contact substances, pharmaceuticals, med
'/>"/>

SOURCE Spherix Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Spherix Announces Second Quarter Financial Results
2. Spherix Drug Candidate SPX-106 Shows Statistically Significant Reductions in Serum Triglycerides in Preclinical Testing
3. Spherix Announces Registered Direct Offering of $2.77 Million
4. Spherix Announces Post-Hoc Analysis of Phase 3 Trial With D-Tagatose in Diabetes
5. Spherix Announces Third Quarter 2010 Financial Results
6. Spherix Awarded Grant from U.S. Government Under the Patient Protection and Affordable Care Act
7. Spherix Announces Institutional Investors Purchase $5.25 Million of Convertible Preferred Stock and Warrants
8. Spherix Completes Enrollment in NEET, a Phase 3 Clinical Trial Evaluating an Oral Drug for Type 2 Diabetes
9. Spherix to Present at Annual OneMedPlace Finance Forum and at EBD Biotech Showcase in San Francisco
10. Spherix Reports Third Quarter 2009 Earnings
11. Spherix Announces Positive Phase 2 Study Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... The National Association of Drug Diversion ... by the real-time, pseudoephedrine (PSE) blocking system in ... Exchange (NPLEx), automatically blocks unlawful pseudoephedrine sales and ... and make arrests. Data released by NPLEx shows ... blocked the sale of more than 7,481 boxes of ...
(Date:8/20/2014)... Reportlinker.com announces that a new market ... The Impact of Healthcare Reform (PPACA) On ... http://www.reportlinker.com/p01618927/The-Impact-of-Healthcare-Reform-PPACA-On-the-US-IVD-Industry.html The "Patient Protection and ... that affects virtually every aspect of health care, ... take effect now. IVD manufacturers who have different ...
(Date:8/20/2014)... 2014 Research and Markets ... Biosimilars/Follow-on-Biologics Market (Technology, Types, Applications, Services and Geography) ... to their offering. A new ... geography) - Size, Share, Global Trends, Company Profiles, ... Forecast, 2013 - 2020", suggests that the global ...
Breaking Medicine Technology:Kansas's Stop-Sale System Achieves Significant Results In Battle Against Meth 2The Impact of Healthcare Reform (PPACA) On the U.S. IVD Industry 2The Impact of Healthcare Reform (PPACA) On the U.S. IVD Industry 3The Impact of Healthcare Reform (PPACA) On the U.S. IVD Industry 4The Impact of Healthcare Reform (PPACA) On the U.S. IVD Industry 5The Impact of Healthcare Reform (PPACA) On the U.S. IVD Industry 6Global Biosimilars/Follow-on-Biologics Market (Technology, Types, Applications, Services and Geography) - Research Report, 2013 - 2020 2
... 24, 2012   Sanovas , a leading developer ... cancer and chronic diseases, announced today that it ... manufacturing site in Sausalito, Calif. The facility will ... of filing for U.S. Food and Drug Administration ...
... Medical Inc. (OTCBB:ONCS), which is developing its ... therapies to treat solid tumor cancers, today announced ... OncoSec, will be presenting at the World Cancer ... (Logo:  http://photos.prnewswire.com/prnh/20110314/MM64943LOGO ) ...
Cached Medicine Technology:Sanovas Expands Headquarters and Opens Manufacturing Site 2OncoSec to Present at World Cancer Immunotherapy Conference 2OncoSec to Present at World Cancer Immunotherapy Conference 3
(Date:8/20/2014)... in Australia examined patient and tumor characteristics for ... tumor cell growth) in an effort to increase ... , Author: Sarah Shen, M.B.B.S., ... colleagues. , Background: The tumor characteristic known ... been connected with prognosis and survival in melanoma ...
(Date:8/20/2014)... researchers have discovered that the immune system is defective ... major reason why sufferers have ongoing issues with pain. , ... world could also help to explain why some painkillers ... syndrome (IBS) affects up to 10% of the community. ... involve unexplained gut pain, which often has the greatest impact ...
(Date:8/20/2014)... vaccines is now, Free content, The time to ... commentary being published early online today in ... Yale School of Public Health write that the relentless ... outbreak represent a public health crisis that shows no ... have been developed in the last decade, yet the ...
(Date:8/20/2014)... -- Pigs, hearts transplanted into baboons survived for more ... previously achieved, researchers report. The work is part ... to shorten transplant waiting lists. In this study, ... abdomens. The genetic engineering and new methods of suppressing ... hearts to survive for more than a year. ...
(Date:8/20/2014)... (HealthDay News) -- Loss of brain cells that act ... seniors have trouble falling and staying asleep, a new ... be especially severe and often results in nighttime confusion ... analyzed data from the Rush Memory and Aging Project, ... 65 and are being followed until death, at which ...
Breaking Medicine News(10 mins):Health News:Patient, tumor characteristics for high-mitotic rate melanoma 2Health News:Pain treatments less effective for those with irritable bowel 2Health News:News from Annals of Internal Medicine 2Health News:Pigs' Hearts Beat for a Year in Baboons' Abdomens 2Health News:Seniors' Sleep Woes May Be Linked to Loss of Brain Cells 2
... Goodwin HealthDay Reporter , WEDNESDAY, March 14 ... with acute myeloid leukemia, researchers were able to more ... going into remission, and which ones would respond well ... Doctors from Memorial Sloan-Kettering Cancer Center in New York ...
... HealthDay Reporter , WEDNESDAY, March 14 (HealthDay News) -- People ... a genetic predisposition to be overweight, compared to those who ... The findings don,t prove that the exercise is the ... something else could explain why those who walked were thinner, ...
... of UCLA suggested that meditating for years thickens the ... between brain cells. Now a further report by UCLA ... Luders, an assistant professor at the UCLA Laboratory of ... have larger amounts of gyrification ("folding" of the cortex, ...
... acts of racial discrimination is enough to depress anyone, ... to stress with stoicism and emotional control experience more ... of North Carolina at Chapel Hill. The study, ... Moderators of the Racial DiscriminationDepressive Symptoms Association Among African-American ...
... molecules in a drop of a patient,s blood to detect ... drug ferry that doesn,t release its toxic contents until it ... be game changers in how we diagnose, monitor and treat ... the California Institute of Technology, and a member of the ...
... infected with hepatitis C virus (HCV) would likely ... published in Clinical Infectious Diseases and ... mortality and morbidity, however, will require a coordinated ... also linking those infected with the treatment they ...
Cached Medicine News:Health News:Detailed Gene Scan Might Help Guide Leukemia Treatment 2Health News:Detailed Gene Scan Might Help Guide Leukemia Treatment 3Health News:Detailed Gene Scan Might Help Guide Leukemia Treatment 4Health News:Brisk Daily Walk Could Counter 'Obesity Genes' 2Health News:Evidence builds that meditation strengthens the brain, UCLA researchers say 2Health News:Hiding emotions may exacerbate depression among black men who confront racial discrimination 2Health News:Fighting cancer with nanotechnology 2Health News:Broader screening for hepatitis C would be cost effective, study suggests 2
... linear stapler with LACTOMER™ 9-1 absorbable ... POLY CS™-57 disposable surgical stapler has ... temporary opening, such as a hysterotomy ... when transecting muscle tissue, to maintain ...
... Units With Titanium Staples for ... (Single Use Reloadable Stapler with ... Suture™ PREMIUM MULTIFIRE TA™ stapler ... pediatric and thoracic surgical procedures ...
... Use Loading Units for use ... Use Reloadable Staplers with Titanium ... TA™ Reloadable staplers has application ... thoracic surgical procedures for resection ...
... linear stapler for resection, transection and anastomosis ... MULTIFIRE GIA™ 60 and 80 single use ... 80 single use loading units and the ... use surgical stapler with MULTIFIRE SGIA™ 60 ...
Medicine Products: